118 related articles for article (PubMed ID: 23230145)
1. N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.
Yabuta N; Mukai S; Okamoto A; Okuzaki D; Suzuki H; Torigata K; Yoshida K; Okada N; Miura D; Ito A; Ikawa M; Okabe M; Nojima H
J Cell Sci; 2013 Jan; 126(Pt 2):508-20. PubMed ID: 23230145
[TBL] [Abstract][Full Text] [Related]
2. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
[TBL] [Abstract][Full Text] [Related]
3. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
4. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
6.
Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
[TBL] [Abstract][Full Text] [Related]
7. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.
Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW
J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415
[TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway member Nf2 is required for inner cell mass specification.
Cockburn K; Biechele S; Garner J; Rossant J
Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
[TBL] [Abstract][Full Text] [Related]
9. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
[TBL] [Abstract][Full Text] [Related]
10. Dual Role of a C-Terminally Truncated Isoform of Large Tumor Suppressor Kinase 1 in the Regulation of Hippo Signaling and Tissue Growth.
Matsui Y; Zhang Y; Paulson RF; Lai ZC
DNA Cell Biol; 2019 Jan; 38(1):91-106. PubMed ID: 30461308
[TBL] [Abstract][Full Text] [Related]
11. Cell type-dependent function of LATS1/2 in cancer cell growth.
Pan WW; Moroishi T; Koo JH; Guan KL
Oncogene; 2019 Apr; 38(14):2595-2610. PubMed ID: 30531839
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
Mohad V; Lungova V; Verheyden J; Thibeault SL
Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
[TBL] [Abstract][Full Text] [Related]
13. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
14. Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes.
Zhou PJ; Wang X; An N; Wei L; Zhang L; Huang X; Zhu HH; Fang YX; Gao WQ
Oncogene; 2019 Mar; 38(12):2192-2205. PubMed ID: 30467379
[TBL] [Abstract][Full Text] [Related]
15. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.
Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF
Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
[TBL] [Abstract][Full Text] [Related]
18.
Li L; Dong L; Wang Y; Zhang X; Yan J
Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
[TBL] [Abstract][Full Text] [Related]
19. LATS1 tumor suppressor regulates G2/M transition and apoptosis.
Xia H; Qi H; Li Y; Pei J; Barton J; Blackstad M; Xu T; Tao W
Oncogene; 2002 Feb; 21(8):1233-41. PubMed ID: 11850843
[TBL] [Abstract][Full Text] [Related]
20. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
